These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20375570)

  • 1. Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis strain 381.
    Carlisle MD; Srikantha RN; Brogden KA
    J Innate Immun; 2009; 1(2):118-22. PubMed ID: 20375570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis.
    Dietrich DE; Xiao X; Dawson DV; Bélanger M; Xie H; Progulske-Fox A; Brogden KA
    Infect Immun; 2008 Dec; 76(12):5714-20. PubMed ID: 18852241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-β-defensin 3 and affect peptide's antibacterial activity in vitro.
    Maisetta G; Brancatisano FL; Esin S; Campa M; Batoni G
    Peptides; 2011 May; 32(5):1073-7. PubMed ID: 21335044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor 2 mediates human beta-defensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis.
    Dommisch H; Chung WO; Rohani MG; Williams D; Rangarajan M; Curtis MA; Dale BA
    Infect Immun; 2007 Sep; 75(9):4326-33. PubMed ID: 17591792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus helveticus SBT2171 upregulates the expression of β-defensin and ameliorates periodontal disease caused by Porphyromonas gingivalis.
    Kobatake E; Kobayashi R; Kabuki T; Kurita-Ochiai T
    Microbiol Immunol; 2019 Aug; 63(8):293-302. PubMed ID: 31209914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea extract and its major constituent, epigallocatechin-3-gallate, induce epithelial beta-defensin secretion and prevent beta-defensin degradation by Porphyromonas gingivalis.
    Lombardo Bedran TB; Feghali K; Zhao L; Palomari Spolidorio DM; Grenier D
    J Periodontal Res; 2014 Oct; 49(5):615-23. PubMed ID: 24206194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D reduces the inflammatory response by Porphyromonas gingivalis infection by modulating human β-defensin-3 in human gingival epithelium and periodontal ligament cells.
    De Filippis A; Fiorentino M; Guida L; Annunziata M; Nastri L; Rizzo A
    Int Immunopharmacol; 2017 Jun; 47():106-117. PubMed ID: 28384529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide.
    Li L; Bian T; Lyu J; Cui D; Lei L; Yan F
    Int Immunopharmacol; 2016 Sep; 38():204-13. PubMed ID: 27289299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-tocopherol decreases interleukin-1β and -6 and increases human β-defensin-1 and -2 secretion in human gingival fibroblasts stimulated with Porphyromonas gingivalis lipopolysaccharide.
    Derradjia A; Alanazi H; Park HJ; Djeribi R; Semlali A; Rouabhia M
    J Periodontal Res; 2016 Jun; 51(3):295-303. PubMed ID: 26214284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice.
    Kohlgraf KG; Ackermann A; Lu X; Burnell K; Bélanger M; Cavanaugh JE; Xie H; Progulske-Fox A; Brogden KA
    Future Microbiol; 2010 Jan; 5(1):115-25. PubMed ID: 20020833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral mechanisms of human defensins.
    Wilson SS; Wiens ME; Smith JG
    J Mol Biol; 2013 Dec; 425(24):4965-80. PubMed ID: 24095897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response.
    Pingel LC; Kohlgraf KG; Hansen CJ; Eastman CG; Dietrich DE; Burnell KK; Srikantha RN; Xiao X; Bélanger M; Progulske-Fox A; Cavanaugh JE; Guthmiller JM; Johnson GK; Joly S; Kurago ZB; Dawson DV; Brogden KA
    Immunol Cell Biol; 2008; 86(8):643-9. PubMed ID: 18711400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of Staphylococcal enterotoxin B-mediated immune activation on intestinal defensins.
    Dhaliwal W; Kelly P; Bajaj-Elliott M
    Clin Exp Immunol; 2009 May; 156(2):263-70. PubMed ID: 19386083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Processing of {alpha}- and {beta}-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7).
    Wilson CL; Schmidt AP; Pirilä E; Valore EV; Ferri N; Sorsa T; Ganz T; Parks WC
    J Biol Chem; 2009 Mar; 284(13):8301-11. PubMed ID: 19181662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of {beta}-defensin resistance in the oral anaerobe Porphyromonas gingivalis.
    Shelburne CE; Coulter WA; Olguin D; Lantz MS; Lopatin DE
    Antimicrob Agents Chemother; 2005 Jan; 49(1):183-7. PubMed ID: 15616294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF2L1, a component of the endoplasmic reticulum chaperone complex, differentially interacts with {alpha}-, {beta}-, and {theta}-defensin propeptides.
    Tongaonkar P; Selsted ME
    J Biol Chem; 2009 Feb; 284(9):5602-9. PubMed ID: 19109254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defensins in Viral Infection and Pathogenesis.
    Holly MK; Diaz K; Smith JG
    Annu Rev Virol; 2017 Sep; 4(1):369-391. PubMed ID: 28715972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent.
    Bachrach G; Altman H; Kolenbrander PE; Chalmers NI; Gabai-Gutner M; Mor A; Friedman M; Steinberg D
    Antimicrob Agents Chemother; 2008 Feb; 52(2):638-42. PubMed ID: 18086848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor signaling increases epithelial antimicrobial peptide expression.
    Chung WO; Hansen SR; Rao D; Dale BA
    J Immunol; 2004 Oct; 173(8):5165-70. PubMed ID: 15470061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the research and development of human defensins.
    Chen H; Xu Z; Peng L; Fang X; Yin X; Xu N; Cen P
    Peptides; 2006 Apr; 27(4):931-40. PubMed ID: 16226346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.